| [1] |
Feng Siqi, Ni Yuchen, Hu Fengyi, Liu Yue, Ye Xiaofei, Guo Xiaojing.
Long-term post-marketing safety surveillance of cell therapy products: international experience and optimization pathways in China
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(9): 975-981.
|
| [2] |
Zhao Zhiwei, Ke Wenyuan, Yang Xue, Chen Xiaobo, Xia Xudong.
1358 case reports of adverse drug reactions induced by iodixanol injection
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(9): 1040-1044.
|
| [3] |
Pan En, Cui Xiaokang, Xu Bin, Rong Youming, Fan Xiao, Ma Xiaodong, Li Xia.
1115 case reports of adverse drug reactions induced by escitalopram oxalate tablets
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(9): 1045-1049.
|
| [4] |
Shang Jiahai, Long Jiaojiao, Liu Yarui, Lu Yuanyuan.
Two cases of conjunctival congestion in children caused by hemocoagulase agkistrodon for injection
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(9): 1050-1052.
|
| [5] |
Wu Qian, Qin Yong, Wang Lushan, Han Zhongyu.
One case of myocarditis caused by gefitinib tablets
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(9): 1053-1055.
|
| [6] |
Sun Lingling, Fang Wei, Wang Yuting, Li Jinfeng, Yang Yilei.
One case of acute severe liver injury caused by chewable tablets of acyclovir
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(9): 1056-1058.
|
| [7] |
Wang Kun, Xu Lei, Wang Cen, Hou Wenping, Liu Junbao, Su Changhai.
One case of chorea caused by digoxin tablets
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(9): 1059-1061.
|
| [8] |
Xing Luyu, Xing Yinghong, Fan Wen, Zhang Shuyi.
One case of rhabdomyolysis caused by piperacillin sodium and tazobactam sodium for injection
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(9): 1062-1064.
|
| [9] |
Xiang Qun, Fu Dali.
Research progress in pathogenic drugs related to drug-induced cognitive impairment and disease risk assessment
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(9): 1075-1080.
|
| [10] |
Lyu Xinge, Liu Aijia, Wu Yi, Pan Chen, Wang Yuting, Cui Xiangli.
Multicenter case analysis of thyroid dysfunction associated with immune checkpoint inhibitors
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(8): 892-897.
|
| [11] |
Li Jianping, Du Ning, Tang Min, Zhou Ziyuan, Zuo Jing.
691 cases of adverse drug reactions caused by new antineoplastic drugs
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(8): 904-908.
|
| [12] |
Bai Liqin, Nie Hongke, Yang Shuting, Jiang Xiaofeng.
214 cases of adverse drug reactions caused by inosine injection
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(8): 909-913.
|
| [13] |
Zhang Yumao, Liu Junbo, Luo Qianjiang, Tan Binying, Deng Bin, Xing Weiqing, Li Yuzhen.
Two cases of hematemesis caused by polyethylene glycol electrolytes powder (Ⅱ) during bowel preparation
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(8): 931-933.
|
| [14] |
Gao Chaozheng, Zhao Yifan, Su Li, Li Ping.
Two cases of acute systemic pain caused by sacituzumab tirumotecan for injection in cancer patients
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(8): 934-937.
|
| [15] |
Xie Huali, Guan Bixi, Zhuo Yubo, He Jieli, Chen Zhe.
One case of sequential delayed-to-immediate hypersensitivity reaction caused by sacituzumab tirumotecan for injection
[J]. Chinese Journal of Pharmacovigilance, 2026, 23(8): 938-940.
|